Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
21
pubmed:dateCreated
2000-11-22
pubmed:abstractText
Serum PSA has been commercially available for more than ten years, and has proved to be the most important tumour marker for prostate cancer. We review the clinical usefulness and limitations of serum PSA as a tumour marker of prostate cancer.
pubmed:commentsCorrections
pubmed:language
nor
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0029-2001
pubmed:author
pubmed:issnType
Print
pubmed:day
10
pubmed:volume
120
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2528-31
pubmed:dateRevised
2008-7-16
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
[Prostate-specific antigen].
pubmed:affiliation
Institutt for abdominale fag, Det medisinske fakultet, Norges teknisk-naturvitenskapelige universitet, Trondheim.
pubmed:publicationType
Journal Article, English Abstract, Review